Cargando…
Early versus Deferred Treatment for Smoldering Multiple Myeloma: A Meta-Analysis of Randomized, Controlled Trials
PURPOSE: Whether patients with smoldering multiple myeloma (SMM) needed to receive early interventional treatment remains controversial. Herein, we conducted a meta-analysis comparing the efficacy and safety of early treatment over deferred treatment for patients with SMM. METHODS: MEDLINE and Cochr...
Autores principales: | Gao, Minjie, Yang, Guang, Tompkins, Van S., Gao, Lu, Wu, Xiaosong, Tao, Yi, Hu, Xiaojing, Hou, Jun, Han, Ying, Xu, Hongwei, Zhan, Fenghuang, Shi, Jumei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184905/ https://www.ncbi.nlm.nih.gov/pubmed/25279718 http://dx.doi.org/10.1371/journal.pone.0109758 |
Ejemplares similares
-
Smoldering Multiple Myeloma
por: Gao, Minjie, et al.
Publicado: (2015) -
Early or deferred treatment of smoldering multiple myeloma: a meta-analysis on randomized controlled studies
por: Zhao, Ai-Lin, et al.
Publicado: (2019) -
TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma
por: Tao, Yi, et al.
Publicado: (2017) -
Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I
por: Yang, Guang, et al.
Publicado: (2015) -
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
por: Boyle, Eileen M., et al.
Publicado: (2021)